GCCL, a leading South Korea-based provider of clinical trial sample analysis, and OPIS, a global full-service contract research organization (CRO), have signed a Memorandum of Understanding (MOU) on the sidelines of the 44th Annual J.P. Morgan Healthcare Conference 2026 in San Francisco, USA, to expand their collabora…
Zydus Lifesciences Limited is an innovation-led life-sciences company with an international presence, announced the successful closure of the Asset Purchase Agreement, Share Purchase Agreement, and the exclusive Licensing Agreement with Agenus Inc. This comprehensive closure follows the receipt of all the necessary re…
Boston Scientific Corporation and Penumbra, Inc., announced the companies have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in a cash and stock transaction that values Penumbra at $374 per share, reflecting an enterprise value of approximately $14.5 billion. "Penumbra is a w…
Under the ownership and leadership of CEO Jimmy St. Louis, Agentis Longevity has completed the acquisition of Arete Wellness, the performance-driven health platform founded by Adam Bobo and Van Hunt, uniting two leaders in longevity medicine and human optimization under a shared mission to help people live healthier, …
Rakuten Medical, Inc. and LOTTE Biologics announced that they have signed a biopharmaceutical contract manufacturing agreement during the J.P. Morgan Healthcare Conference in San Francisco to strengthen Rakuten Medical's production capabilities for its innovative oncology therapy, Alluminox® platform-based photoimmuno…
TetraScience, the Scientific Data and AI company, announced a collaboration with Thermo Fisher Scientific Inc., the world leader in serving science, with a goal of accelerating AI across biopharma R&D and manufacturing by transforming scientific data into AI-native form and developing intelligent workflows at scal…
Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery through innovative technology platforms, announced that it has entered into a multi-target antibody discovery collaboration with Link Cell Therapies. This collaboration will leverage Nona's proprietary fully human HCAb Harbour Mice…
CytoReason, a leader in AI-powered computational disease modeling, announced the expansion of its collaboration with Sanofi for the third time. This multi-year agreement, valued at up to $16 million, further solidifies their partnership. CytoReason technology enables researchers to extract insights from molecular and…
Veeva Systems and BioMarin Pharmaceutical Inc. announced a long-term enterprise agreement that builds upon their long-standing relationship. The expanded partnership will help BioMarin increase speed, agility, operational efficiency, and optimize the healthcare professional and patient experience by further leverag…
MediLink Therapeutics announced that it has entered into a new collaboration and exclusive licensing agreement with Roche for the development and commercialization of YL201, an investigational novel antibody-drug conjugate (ADC) asset targeting B7H3 across numerous solid tumor types. Under the terms of the agreement,…
Page 25 of 43